Skip to content

Clinical trials

Phase 2 Dermatitis, Atopic trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatitis, Atopic Phase: Phase 2 Country / region: Australia Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20111
20121
20131
20141
20153
20162
20171
20183
20195
20202
20214
20223
20232
20241
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Terminated5
Active, not recruiting3
Recruiting3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer6
AbbVie2
AstraZeneca2
Evelo Biosciences, Inc.2
MedImmune LLC2
ASLAN Pharmaceuticals1
Akesobio Australia Pty Ltd1
Alphyn Biologics1
Amgen1
Arena Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatitis, Atopic37
Eczema14
Dermatitis4
Lymphoma, Follicular2
Skin Diseases2
Asthma1
Food Hypersensitivity1
Immune System Diseases1
Inflammation1
Meningitis1

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.